Ascendis Pharma A (ASND) Debt Ratio (2021 - 2025)

Ascendis Pharma A (ASND) has 5 years of Debt Ratio data on file, last reported at 0.59 in Q4 2025.

• For the quarter ending Q4 2025, Debt Ratio rose 125.54% year-over-year to 0.59; the trailing twelve-month figure through Dec 2025 stood at 0.59 (up 125.54% YoY), and the FY2025 full-year result was 0.59, up 125.54% from the prior year.
• Debt Ratio improved to 0.59 in Q4 2025, from 0.26 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.76 in Q4 2023 to a low of 0.05 in Q4 2021.
• A 5-year average of 0.41 and a median of 0.37 in 2022 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio surged 597.33% in 2022 and tumbled 65.7% in 2024, its largest moves.
• Tracing ASND's Debt Ratio over 5 years: stood at 0.05 in 2021, then surged by 597.33% to 0.37 in 2022, then soared by 108.35% to 0.76 in 2023, then plunged by 65.7% to 0.26 in 2024, then surged by 125.54% to 0.59 in 2025.
• Business Quant data shows ASND's Debt Ratio at 0.59 in Q4 2025, 0.26 in Q4 2024, and 0.76 in Q4 2023.